Method for efficient delivery of dual site pacing

• US 9,037,238 B2
• Filed: 11/21/2011
• Issued: 05/19/2015
• Est. Priority Date: 11/21/2011
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Michael C Soldner
• Inventors: Stadler, Robert W., Demmer, Wade M., Splett, Vincent E., Sheldon, Todd J.
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): So, Elizabeth K
• Application Number:
  US13/301,084
• Publication Number:
  US 20130131748A1
• Time in Patent Office: 1,275 Days
• Field of Search: None
• US Class Current: 607/17
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation
• CPC Class Codes: A61N 1/3686 configured for selecting the electrode configuration on a lead A61N1/3688 takes precedence
• CPC Class Codes: A61N 1/3712 Auto-capture, i.e. automatic adjustment of the stimulation threshold

Abstract

An implantable device and associated method for delivering a multi-site pacing therapy includes electrodes for sensing cardiac signals and delivering cardiac pacing pulses to a first pacing site along a heart chamber and a therapy delivery module for delivering cardiac pacing pulses to a patient'"'"'s heart via the electrodes. A sensing module measures an activation time at multiple pacing electrode sites along the heart chamber in response to delivering pacing pulses at the first pacing site. A controller is configured to identify a second pacing site from the plurality of pacing electrode sites in response to the activation times measured during pacing at the first site.

Claims

1. A method for controlling a multi-site pacing therapy, the method comprising:

delivering pacing pulses to an electrode positioned at a first pacing site along a heart chamber;

measuring an activation time at each of a plurality of pacing electrode sites along the heart chamber in response to pacing being delivered to the first pacing site; and

identifying a second pacing site from the plurality of electrode sites in response to the activation times measured during pacing at the first pacing site,

the second pacing site identified as one of the plurality of pacing electrode sites having a latest activation time during pacing at the first pacing site,

the second pacing site identified for delivering the multi-site pacing therapy in the heart chamber wherein capture would occur at the first pacing site and at the identified second pacing site.

2. The method of claim 1, further comprising determining a recommended pacing vector configuration for delivering the multi-site pacing therapy comprising the first pacing site and the second pacing site.

3. The method of claim 2, wherein the recommended pacing vector configuration comprises a single bipole defined by the first pacing site and the second pacing site.

4. The method of claim 3, further comprising:

delivering pacing pulses using a bipole defined by the first pacing site electrode and the second pacing site electrode;

determining whether anodal capture is present during pacing delivered using the bipole; and

determining the recommended pacing vector configuration to be the bipole in response to anodal capture being present.

5. The method of claim 2, further comprising:

performing a capture threshold test for the first pacing site and the second pacing site using the selected pacing vector configuration;

determining whether there is a change in a capture threshold at one of the first pacing site and the second pacing site; and

determining a different recommended pacing vector configuration in response to a determined change in a capture threshold at one of the first pacing site and the second pacing site.

6. The method of claim 5, further comprising;

monitoring for loss of capture during the multi-site pacing therapy delivery; and

performing the capture threshold test in response to detecting the loss of capture.

7. The method of claim 1, further comprising transmitting data corresponding to the activation times and the identified second pacing site from an implantable medical device to an external device.

8. The method of claim 1, further comprising:

sensing a cardiac signal;

determining whether tissue at the identified second pacing site corresponds to pathological tissue in response to the cardiac signal; and

identifying an alternative second pacing site in response to determining tissue at the identified second pacing site corresponds to pathological tissue.

9. The method of claim 8, wherein determining whether tissue at the identified second pacing site corresponds to pathological tissue comprises at least one of measuring a pacing capture threshold at the second pacing site, measuring a time interval to a pacing evoked QRS signal during pacing at the second site, and analyzing a QRS morphology sensed at the second pacing site.

10. The method of claim 1, further comprising delivering the multi-site therapy at the first pacing site and the identified second pacing site, wherein delivering the therapy comprises delivering cardiac resynchronization therapy, and wherein the first site and the second site are located along the left ventricle.

11. A medical device for delivering a multi-site pacing therapy, comprising:

a plurality of electrodes to sense cardiac signals and deliver cardiac pacing pulses to a first pacing site along a heart chamber;

a therapy delivery module to deliver cardiac pacing pulses to a patient'"'"'s heart via the plurality of electrodes;

a sensing module to measure an activation time at each of a plurality of second sites along the heart chamber in response to delivering pacing pulses at the first pacing site; and

a controller configured to identify a second pacing site from the plurality of second electrode sites in response to the activation times measured during pacing at the first pacing site,

the second pacing site identified as one of the plurality of pacing electrode sites having a latest activation time during pacing at the first pacing site,

the second pacing site identified for delivering the multi-site pacing therapy in the heart chamber wherein capture would occur at the first pacing site and at the identified second pacing site.

12. The device of claim 11, wherein the controller is further configured to determine a recommended pacing vector configuration for delivering the multi-site pacing therapy comprising the first pacing site and the second pacing site.

13. The device of claim 12, wherein the recommended pacing vector configuration comprises a single bipole defined by the first pacing site and the second pacing site.

14. The device of claim 13, wherein determining the recommended pacing vector configuration comprises:

controlling the therapy delivery module to deliver pacing pulses using a bipole defined by the first pacing site electrode and the second pacing site electrode;

determining whether anodal capture is present during pacing delivered using the bipole in response to the sensed cardiac signals; and

determining the recommended pacing vector configuration to be the bipole in response to anodal capture being present.

15. The device of claim 12, wherein the controller is further configured to:

perform a capture threshold test for the first pacing site and the second pacing site using the selected pacing vector configuration; and

determine a different recommended pacing vector configuration in response to a change in a capture threshold determined at one of the first pacing site and the second pacing site.

16. The device of claim 15, wherein the controller is further configured to:

control the therapy delivery module to deliver the multi-site pacing therapy using the recommended pacing vector;

monitor for loss of capture during the multi-site pacing therapy delivery; and

perform the capture threshold test in response to detecting the loss of capture.

17. The device of claim 11, wherein the device comprises a transmitter to transmit data corresponding to the activation times and the identified second pacing site to an external device.

18. The device of claim 11, wherein the controller is further configured to determine whether tissue at the identified second site corresponds to pathological tissue in response to the cardiac signal;

and

identify an alternative second pacing site in response to tissue at the identified second site being determined to correspond to pathological tissue.

19. The device of claim 18, wherein the controller is further configured to perform at least one of measuring a pacing capture threshold at the second pacing site, measuring a time interval to a pacing evoked QRS signal during pacing at the second site, and analyzing a QRS morphology sensed at the second pacing site.

20. The device of claim 11, wherein the controller is configured to deliver the multi-site therapy at the first pacing site and the identified second pacing site, delivering the therapy comprises delivering a cardiac resynchronization therapy, and wherein the first site and the second site are along the left ventricle.

21. A non-transitory computer-readable medium storing a set of instructions which when implemented in a medical device cause the device to perform a method for detecting anodal capture, the method comprising:

delivering pacing pulses to an electrode positioned at a first pacing site along a heart chamber;

measuring an activation time at each of a plurality of pacing electrode sites along the heart chamber in response to pacing being delivered to the first pacing site; and

identifying a second pacing site from the plurality of second electrode sites in response to the activation times measured during pacing at the first pacing site,

the second pacing site identified as one of the plurality of pacing electrode sites having a latest activation time during pacing at the first pacing site,

the second pacing site identified for delivering the multi-site pacing therapy in the heart chamber wherein capture would occur at the first pacing site and at the identified second pacing site.